Conversely, in dermatomyositis, skin symptoms accompany ... Regrettably, deceptive situations occur where rheumatology ...
Most patients with Dermatomyositis (DM ... Dr. Julie Paik is an Associate Professor of Medicine in the Division of Rheumatology at Johns Hopkins University School of Medicine, where she serves ...
She then pursued a rheumatology fellowship at Johns Hopkins ... scleroderma and developing novel therapeutics for refractory dermatomyositis. She has led investigations on JAK inhibitor therapy ...
it is up to us pediatric rheumatologists to ensure that adult ... Kawasaki disease, dermatomyositis and localized scleroderma. Despite therapeutic progress being made, many PRDs constitute a ...
A study found that both dermatomyositis (DM) and clinically amyopathic dermatomyositis (CADM) were commonly misdiagnosed as inflammatory skin disease (ISD), particularly CADM, which was also ...
Biologic agents targeting IL-6 (such as tocilizumab) are already used in the clinic to treat other autoimmune inflammatory disorders including rheumatoid arthritis, prompting Kohsaka et al.